Online Inquiry

C15 Ceramide (d18:1/15:0)

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Standards
Catalog NO. BPG-3153
Product Name C15 Ceramide (d18:1/15:0)
CAS 67492-15-3
Molecular Formula C33H65NO3
Molecular Weight 523.87
C15 Ceramide (d18:1/15:0)
  • Scheme Design
  • Custom Synthesis
  • cGMP Manufacturing
  • Quality Assurance
  • Product Information
  • Application
  • References
  • Documents
  • Reviews

Product Information

Description C15 Ceramide (d18:1/15:0) is a naturally occurring ceramide that has been found in L. nidifica and A. glomerata extracts, human erythrocytes, and the stratum corneum of P. domesticus. Ceramide plays a key role in the anabolic and catabolic pathways of sphingolipids. It acts as an extracellular stimuli for many cellular processes like differentiation, growth suppression, cell senescence and apoptosis.
Synonyms N-(pentadecanoyl)-4E-sphingenine; N-pentadecanoyl-D-erythro-sphingosine; Cer(d18:1(4E)/15:0); C15 D-erythro Ceramide (d18:1/15:0)
IUPAC Name N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]pentadecanamide
Canonical SMILES CCCCCCCCCCCCCCC(=O)NC(CO)C(C=CCCCCCCCCCCCCC)O
InChI InChI=1S/C33H65NO3/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-32(36)31(30-35)34-33(37)29-27-25-23-21-19-16-14-12-10-8-6-4-2/h26,28,31-32,35-36H,3-25,27,29-30H2,1-2H3,(H,34,37)/b28-26+/t31-,32+/m0/s1
InChIKey HBULQAPKKLNTLT-STSAHMJASA-N
Purity >99%
Shelf Life 1 Year
Storage Store at -20°C
Exact Mass 523.5
Hygroscopic No
Light Sensitive No
Percent Composition C 75.66%, H 12.51%, N 2.67%, O 9.16%

C15 Ceramide (d18:1/15:0) is widely regarded for its pivotal role in dermatological applications, particularly in skincare products aimed at enhancing barrier function. The molecule's ability to repair and reinforce the skin's natural barrier is essential for individuals with conditions such as eczema and psoriasis. By integrating C15 Ceramide into moisturizers and topical treatments, manufacturers address common issues like dehydration, irritation, and sensitivity. This biochemical marvel restores the lipid structure in the stratum corneum, leading to improved skin hydration and resilience. Such properties make it a star ingredient in high-performance skincare formulations focused on barrier repair and maintenance.

Beyond skincare, C15 Ceramide (d18:1/15:0) holds promise in the field of neurobiology. Ceramides play a crucial role in neuronal signaling and brain health, with particular emphasis on their involvement in cell signaling pathways related to growth, differentiation, and apoptosis. Research into ceramide's impact on neurodegenerative diseases like Alzheimer's and Parkinson's is burgeoning. By modulating ceramide levels in neural tissues, scientists aim to decipher new therapeutic strategies that could slow or even reverse disease progression, offering hope for enhanced cognitive function and neuroprotection.

In oncology, C15 Ceramide (d18:1/15:0) is investigated for its potential anti-cancer properties. Ceramide is known to induce apoptosis in cancer cells, making it a focal point for developing novel treatments. Researchers explore how manipulating ceramide metabolism or mimicking its effects can potentially starve tumors of their proliferative capabilities. By understanding and harnessing ceramide's apoptotic pathways, new chemotherapeutic agents aim not only to kill cancer cells more efficiently but to reduce the side effects compared to traditional treatments. The specificity and potency of C15 Ceramide in triggering cancer cell death present a promising avenue for future anti-cancer therapies.

Lastly, C15 Ceramide (d18:1/15:0) finds crucial applications in the area of metabolic diseases, including diabetes and obesity. Ceramides are implicated in the regulation of insulin signaling and lipid metabolism. Elevated levels of certain ceramides are associated with insulin resistance and metabolic dysregulation. By targeting ceramide synthesis or its metabolic pathways, researchers hope to develop new interventions that improve insulin sensitivity and metabolic outcomes. Such advancements could lead to innovative treatments that better manage or even prevent metabolic syndrome, reducing the burden of these pervasive health challenges.

References 1. Régnier M, Polizzi A, Smati S, Lukowicz C, Fougerat A, Lippi Y, Fouché E, Lasserre F, Naylies C, Bétoulières C, Barquissau V, Mouisel E, Bertrand-Michel J, Batut A, Saati TA, Canlet C, Tremblay-Franco M, Ellero-Simatos S, Langin D, Postic C, Wahli W, Loiseau N, Guillou H, Montagner A. Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity. Sci Rep. 2020 Apr 16;10(1):6489. doi: 10.1038/s41598-020-63579-3. PMID: 32300166; PMCID: PMC7162950. PubMed ID: 32300166.

Reviews

If you have any suggestions or comments about mPEG-Br, please submit a review immediately.

submit

Related Link

Why BOC Sciences?

  • Large Stock

    More than 2000+ products in inventory

  • Global Delivery

    Warehouses in multiple cities to ensure fast delivery

  • mg to kg

    Multi specification for academic research and industrial production

  • 24/7 Technical Support

    Strict process parameter control to ensure product quality

Products

Resources

Our Feature

BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.

  • Our Feature icon1
  • Our Feature icon2
  • Our Feature icon3
  • Our Feature icon4
PEGylation of Peptides and Proteins

PEGylation of Peptides
and Proteins

Reduce the Immunogenicity of Peptide/Protein Drugs

Learn More

APPLICATIONS

APPLICATIONS

PEG linkers For Drug

Improved Circulation Half-Life

Learn More

Have Customer Reviewed On Us?

logo

Chat With Us

Online Inquiry

Verification code

Copyright © 2024 BOC Sciences. All rights reserved.

Inquiry Basket